Literature DB >> 805509

Epidemiological markers for pseudomonas aeruginosa.

T Bergan, T Midtvedt.   

Abstract

A non-lysogenic strain of Pseudomonas aeruginosa maintained its phage sensitivity pattern and serogroup specificity unchanged for 10 weeks in ex-germfree, mono-contaminated rats before infection with phage. After infection with phage, phage conversions of serogroup specificity and lysotype were observed. With the same combination of bacterial and phage strains, the same serogroup was obtained in vitro and in vivo. In vitro conversion occurred also to serogroups that were not detected in vivo. Upon lyophilization, converted bacterial clones from the in vivo experiment lost their phage and simultaneously reverted to the original phage type and serogroup. These findings may have implications for the understanding of the degree of stability in epidemiological typing results for P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 805509     DOI: 10.1111/j.1699-0463.1975.tb00062.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand B        ISSN: 0105-0656


  4 in total

1.  O-antigen conversion in Pseudomonas aeruginosa PAO1 by bacteriophage D3.

Authors:  J Kuzio; A M Kropinski
Journal:  J Bacteriol       Date:  1983-07       Impact factor: 3.490

2.  Phage-related surface modifications of Pseudomonas aeruginosa: effects on the biological activity of viable cells.

Authors:  G Dimitracopoulos; P F Bartell
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

3.  Serological typing of Pseudomonas aeruginosa: use of commercial antisera and live antigens.

Authors:  C D Brokopp; R Gomez-Lus; J J Farmer
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

4.  Bacteriophages Synergize with the Gut Microbial Community To Combat Salmonella.

Authors:  Juan Du; Lars Engstrand; Yue O O Hu; Luisa W Hugerth; Carina Bengtsson; Arlisa Alisjahbana; Maike Seifert; Anaga Kamal; Åsa Sjöling; Tore Midtvedt; Elisabeth Norin
Journal:  mSystems       Date:  2018-10-02       Impact factor: 6.496

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.